The investigation has determined that higher than expected vitros intact pth (ipth) results were obtained from multiple samples from a single patient processed using vitros immunodiagnostic products intact pth reagent lot 1820 on a vitros 5600 integrated system.The results were higher than expected when compared to the initial results for the patient.A definitive assignable cause could not be determined.The customer made no suggestion of any issues with the quality control fluids processed at the customer site and no issues regarding accuracy or precision of the vitros assay were indicated.As precision testing was not performed on the vitros 5600 system, no assessment of the instrument¿s performance at the time of the event was made.However, the customer gave no indication of any vitros 5600 system malfunction.Additionally, according to the customer, the results were reproducible for the patient samples.Therefore, an instrument issue is not a likely contributor to the event.Pre-analytical sample processing could not be ruled out as a contributing factor as it is unknown if the customer was following the sample collection device manufacturer¿s recommended centrifugation protocol.Improper pre-analytical sample handling could have contributed to this event.It is possible that cellular debris, due to poor sample preparation, was present in the affected samples, although this could not be confirmed.In addition, a pre-analytical sample mix-up could not be entirely ruled out as a contributor of the event.Continual tracking and trending of complaints has not identified any signals that would point to a potential systemic issue with vitros ipth lot 1820.
|